2018
DOI: 10.1016/j.biomaterials.2018.04.047
|View full text |Cite
|
Sign up to set email alerts
|

Design of a vascularized synthetic poly(ethylene glycol) macroencapsulation device for islet transplantation

Abstract: The use of immunoisolating macrodevices in islet transplantation confers the benefit of safety and translatability by containing transplanted cells within a single retrievable device. To date, there has been limited development and characterization of synthetic poly(ethylene glycol) (PEG)-based hydrogel macrodevices for islet encapsulation and transplantation. Herein, we describe a two-component synthetic PEG hydrogel macrodevice system, designed for islet delivery to an extrahepatic islet transplant site, con… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
121
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 112 publications
(125 citation statements)
references
References 34 publications
(39 reference statements)
4
121
0
Order By: Relevance
“…The diameter of traditional islet encapsulation devices has been limited to a few hundred micrometers to enable sufficient oxygen diffusion from the surrounding environment. [4a,5b] By reducing the thickness of the shell structure through careful design of the coaxial printing nozzle of the 3D PICT system, the distance between every single islet and the surrounding environment can be controlled to less than 400 µm. Combined with appropriate porosity and high surface to volume ratios that can be achieved with a 3D structure design and printing process, a far more favorable microenvironment can be created inside the hydrogel scaffolds to enhance islet survival.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…The diameter of traditional islet encapsulation devices has been limited to a few hundred micrometers to enable sufficient oxygen diffusion from the surrounding environment. [4a,5b] By reducing the thickness of the shell structure through careful design of the coaxial printing nozzle of the 3D PICT system, the distance between every single islet and the surrounding environment can be controlled to less than 400 µm. Combined with appropriate porosity and high surface to volume ratios that can be achieved with a 3D structure design and printing process, a far more favorable microenvironment can be created inside the hydrogel scaffolds to enhance islet survival.…”
Section: Resultsmentioning
confidence: 99%
“…To improve the viability of transplanted islets, various islet encapsulation strategies have been investigated, including macro‐encapsulation of islets in retrievable devices and microencapsulation in hydrogel microspheres. [1b,6] Using the macroencapsulation device, islets can be physically isolated from the surrounding environment by semipermeable cell containment barriers.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Human MSC and Rat Islet Encapsulation and Viability Assay : Rat islets were isolated according to previously published protocols before being resuspended in 20 × 10 −3 m HEPES in PBS at 2× concentration (10 islet equivalent µL −1 ) . The rat islets were mixed at 1:1 ratio with a 2× macromer solution in PBS to achieve a final concentration of 4.0% w/v PEG‐4NB (aNB or eNB), 2.0 × 10 −3 m RGD (GRGDSPC, Genscript), 3.0 × 10 −3 m PEG‐DT, and 0.5 × 10 −3 m LAP.…”
Section: Methodsmentioning
confidence: 99%
“…Open macroporous encapsulation devices that allow revascularization of islets have demonstrated some promise but it still takes at least 7-14 days until a new functional vasculature is established in transplanted islets [3] and immunosuppressants are always required. Macro-and microencapsulation of islets and beta cells are an alternative to open devices that introduce a physical barrier to protect the transplanted islets from the host's immune system, potentially circumventing the need for immunosuppressive therapy [4] and mitigating some risks by protecting the patient from rogue cells in case of induced pluripotent-or embryonic stem cell-derived beta cell therapy [5][6][7][8][9][10][11]. Whatever the strategy chosen, the clinical success of encapsulation devices is hampered by a number of complex factors such as acute and long-term ischemia, limited vascularization and mass transport of crucial nutrients such as oxygen and insulin, and suboptimal biomaterial properties [12].…”
Section: Introductionmentioning
confidence: 99%